Related Experiment Video
Updated: Jun 2, 2026

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
Published on: December 16, 2022
Assessment of Doxorubicin Internalization and Cytotoxicity in Primary Tumor Spheroids After Collagen Digestion
Alessandra Lo Cicero1, Gabriele Lo Buglio1,2, Simona Campora1
1Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.
Abstract:
The limited penetration of chemotherapeutic agents into solid tumors remains a major obstacle to effective cancer treatment and is strongly influenced by the extracellular matrix (ECM). Three-dimensional (3D) tumor spheroids derived from primary tumor cells (PTCs) represent a valuable in vitro model to study how ECM composition and organization regulate drug distribution and cytotoxicity with accurate physiological relevance. By recapitulating key features of the tumor microenvironment, including endogenous collagen deposition and diffusion-limited drug accessibility, these models enable mechanistic investigation of microenvironment-driven drug resistance. Here, we describe a set of integrated protocols to evaluate the impact of ECM remodeling on chemotherapeutic response in primary breast tumor spheroids. Spheroids are generated from isolated primary tumor cells and subjected to controlled enzymatic degradation of collagen-rich ECM using ultrapure recombinant collagenases. As a model chemotherapeutic agent, doxorubicin is employed thanks to its widespread clinical use, well-characterized cytotoxic mechanism, and intrinsic fluorescence, which allows direct visualization of drug uptake and spatial distribution by confocal microscopy. In parallel, drug-induced cytotoxicity is quantified using a luminescent 3D viability assay. Together, these protocols provide a reproducible and accessible platform for investigating ECM-mediated barriers to drug delivery and toxicity in 3D tumor models. This framework facilitates the implementation of physiologically relevant assays to study drug efficacy and therapeutic resistance in solid tumors. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Induction of breast cancer, isolation of tumor primary cells, and generation 3D spheroids Support Protocol: Culture and storage of PTCs Basic Protocol 2: Evaluation of collagen expression and enzymatic degradation in primary tumor spheroids by confocal microscopy Basic Protocol 3: Enzymatic degradation of the endogenous matrix collagen in primary tumor spheroids using recombinant collagenases Basic Protocol 4: Assessment of doxorubicin uptake in spheroids by confocal microscopy Basic Protocol 5: Assessment of cell viability in doxorubicin-treated spheroids using CellTiter-Glo 3D assay.
Insights
This study introduces a new 3D breast tumor model to investigate how the extracellular matrix (ECM) affects chemotherapy delivery and resistance. The model uses primary tumor cells to better understand drug penetration and efficacy in solid tumors.
Area of Science:
- Oncology
- Biomedical Engineering
- Cancer Biology
Background:
- Limited penetration of chemotherapeutic agents into solid tumors is a significant challenge in cancer treatment.
- The extracellular matrix (ECM) plays a crucial role in regulating drug distribution and efficacy within tumors.
- Three-dimensional (3D) tumor spheroids from primary tumor cells (PTCs) offer a physiologically relevant in vitro model to study these interactions.
Purpose of the Study:
- To develop and present integrated protocols for evaluating the impact of ECM remodeling on chemotherapeutic response in primary breast tumor spheroids.
- To establish a reproducible platform for investigating ECM-mediated barriers to drug delivery and toxicity in 3D tumor models.
- To facilitate mechanistic studies of microenvironment-driven drug resistance.
Main Methods:
- Generation of 3D spheroids from isolated primary breast tumor cells.
- Controlled enzymatic degradation of collagen-rich ECM using recombinant collagenases.
- Assessment of doxorubicin uptake and spatial distribution via confocal microscopy.
- Quantification of drug-induced cytotoxicity using a luminescent 3D viability assay.
Main Results:
- The developed protocols allow for the visualization and quantification of drug penetration and efficacy within a 3D tumor microenvironment.
- The model effectively recapitulates key features of solid tumors, including collagen deposition and diffusion-limited drug accessibility.
- The study provides a framework for investigating how ECM composition influences chemotherapeutic response.
Conclusions:
- The described integrated protocols offer a valuable and accessible platform for studying ECM-mediated drug delivery barriers and toxicity in 3D tumor models.
- This approach enhances the physiological relevance of in vitro cancer research, aiding the study of drug efficacy and resistance.
- The findings support the development of more effective cancer therapies by elucidating the role of the tumor microenvironment.

